About Us
Overview
Company Milestones
Our Facilities
Products
Medical Information
Contact Us
About Us
Overview
Company Milestones
Our Facilities
Products
Medical Information
Contact Us
2015 – Zydus began Phase III study of saroglitazar in NASH
Post navigation
Previous:
2014 – Zydus launched world’s first biosimilar of adalimumab
Next:
2016 – Zydus acquired Zoetis, a global animal health company